Google News : U.K. : All
- Mensch snaps up Waldegrave's 'clear-eyed analysis' of post-Brexit referendum Britain - The Bookseller
- New Westminster Cabinet Far to the Right of Thatcher's - Consortium News
- Morgan Stanley Boosts GW Pharmaceuticals PLC- (NASDAQ:GWPH) Price Target to $238.00 - Mayfield Recorder
- GW Pharmaceuticals PLC- (NASDAQ:GWPH) Director William A. Waldegrave Sells 3,576 Shares - Sundance Herald
- Piper Jaffray Companies Weighs in on GW Pharmaceuticals PLC-‘s Q2 2019 Earnings (NASDAQ:GWPH) - Mayfield Recorder
- GW Pharmaceuticals PLC- (NASDAQ:GWPH) Downgraded by ValuEngine - Riverton Roll
- GW Pharmaceuticals PLC- (NASDAQ:GWPH) Receives $212.44 Average PT from Brokerages - Riverton Roll
- GW Pharmaceuticals PLC- (NASDAQ:GWPH) Price Target Raised to $238.00 - Mayfield Recorder
- William A. Waldegrave Sells 3576 Shares of GW Pharmaceuticals PLC- (NASDAQ:GWPH) Stock - Trent Times
- AGF Investments Inc. Buys Shares of 33,205 GW Pharmaceuticals PLC- (NASDAQ:GWPH) - Riverton Roll